Richard Sagebiel, MD
Pathologist
Asbestosis Clubbed Fingers Diffuse Pleural Thickening Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Effusions Pleural Mesothelioma Pleural Plaques Pleuritis Rounded Atelectasis Testicular Mesothelioma
Cancer Antigen 125, CA Fibulin-3 Human MPF ELISA Kit Mesomark Osteopontin SOMAmer Panel
Dr. Richard Sagebiel is a pathologist in San Francisco, California. He has been practicing medicine for more than two decades. He is also an expert dermatologist. Dr. Sagebiel is a board-certified pathologist and dermatologist. He graduated from the Harvard Medical School and continued with an internship at the Harborview Medical Center and a residency stage in anatomic and clinical pathology at the Massachusetts General Hospital. Dr. Richard Sagebiel is an active figure in the medical research field. He contributed to multiple publications that focused on topics like PHIP copy number in melanoma, cancer prognostic predictions, melanoma progression, melanoma risks related to sunbeds and sunlamps, identification of patients at melanoma risk, gene expression signatures, primary liver carcinoma, melanoma variants, Kaposi’s sarcoma, hereditary neurofibromas. Dr. Sagebiel currently works for the California Pacific Medical Center.
Harvard
Medical School
Harborview Medical Center
Internship
Massachusetts General Hospital
Residency
American Board of Pathology
California Pacific Medical Center
Languages: English/Spanish
(415) 600-6000
Castro St & Duboce Ave
San Francisco, California 94114
Prognostic Impact of PHIP Copy Number in Melanoma: Linkage to Ulceration.
Bezrookove, V.,De Semir, D.,Nosrati, M.,Tong, S.,Wu, C.,Thummala, S.,Dar, A. A.,Leong, S. P.,Cleaver, J. E.,Sagebiel, R. W.,Miller, J. R.,Kashani-Sabet, M.; J. Invest. Dermatol.. 2013 Sep 4.
See more >>A patient-centered methodology that improves the accuracy of prognostic predictions in cancer.
Kashani-Sabet, M.,Sagebiel, R. W.,Joensuu, H.,Miller, J. R.; PLoS ONE. 2013.
See more >>The Role of miR-18b in MDM2-p53 Pathway Signaling and Melanoma Progression.
Dar, A. A.,Majid, S.,Rittsteuer, C.,de Semir, D.,Bezrookove, V.,Tong, S.,Nosrati, M.,Sagebiel, R.,Miller, J. R.,Kashani-Sabet, M.; J Natl Cancer Inst. 2013 Mar 20.
See more >>